December 18, 2025 — Leads & Copy — Arcus Biosciences (NYSE:RCUS) CEO Terry Rosen, Ph.D., will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Wednesday, January 14th, 2026, at 3:00 pm PT.
A live webcast of the presentation will be available on the Arcus Biosciences website. A replay will be available following the live event.
Arcus Biosciences, founded in 2015, is focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases. The company is developing its late-stage portfolio of medicines against biological targets and pathways and studying biology-driven combinations that may help people with cancer live longer.
The company has advanced multiple investigational medicines into registrational clinical trials, including casdatifan, a HIF-2a inhibitor for clear cell renal cell carcinoma, and quemliclustat, a small-molecule CD73 inhibitor for pancreatic cancer.
For more information about Arcus Biosciences’ clinical and preclinical programs, visit www.arcusbio.com.
Source: Arcus Biosciences
